Speaking Engagement

Mitigating International Legal Risk: IP Due Diligence Considerations for Global Deals

ACI’s 4th Annual Summit on Life Sciences IP Due Diligence

09 Nov 2020 07:15 p.m. - 08:00 p.m.

Janet Xiao will speak at the summit on Life Sciences IP Due Diligence, a Life Sciences industry think tank for assessing, valuing, and commercializing IP Assets, discussing IP due diligence considerations for global deals to mitigate international legal risk. She is joined by Yu-Ming Dammann, Associate General Counsel, at Gilead Sciences. They will address:

  • Identifying due diligence landmines that U.S. practitioners should avoid when doing deals globally
  • Assessing how the new CFIUS regulations are increasing government scrutiny over foreign investment in U.S. biotech companies, and the impact this has on due diligence relating to deals with such companies
  • Evaluating foreign IP assets based upon the specific rules for their jurisdiction



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.